REVIEW ARTICLE ABOUT HELICOBACTER PYLORI
- Authors
-
-
Mustafa Mohammed Hassan Saleh
University of Samarra / College of Applied Sciences Department Pathological Analysis -
Saja Hassan Hadi Mohammed
University of Karbala College Applied Medical Sciences Department Pathological Analysis -
Ali Mohammed Jawad Hassan
University of Kufa/ Faculty of Science / Department of Pathological Analysis -
Anwar Taha Abbas Khamis
Samarra University Applied Sciences/Pathological Analysis Department -
Bilal Omer Abdullah Hashim
Samarra University Applied Sciences/Pathological Analysis Department
-
- Abstract
-
Helicobacter pylori is a Gram-negative, 0.5-1 μm wide and 2-4 μm long, short spiral microorganism. It is found mostly in the pyloric region of the stomach and causes chronic gastric infection. It is estimated that this bacterium infects more than half of the world's population. The exact mode of transmission of H. pylori infection is still unknown, but fecal-oral routes through water or food consumption are thought to be a very common cause. In the past three decades, research interest has increased regarding pathogenesis, bacterial activity, genetic predisposition, and clinical treatments to understand the severity of gastric atrophy and gastric cancer caused by H. pylori. Studies have suggested an association between H. pylori infection and malabsorption of essential micronutrients, and have noted that H. pylori infection may influence the prevalence of malnutrition in some at-risk groups. On the other hand, dietary factors may play a major role in H. pylori infection, and an adequate and balanced diet, especially high consumption of fruits and vegetables and low consumption of processed salty foods, has been reported to have a protective effect against the outcomes of H. pylori infection. The present review provides an overview of all aspects of H. pylori infection, such as clinical features, treatment, and nutrition.
- References
-
1. Marshall, B. Warren ، J.R. Unknown curved bacilli in the stomach of patients with gastritis and peptic ulcer. Lancet 1984 , 1 , 1311-1315
2. Koesters, JJ; van Vliet, AH; Kuipers, E. Pathogenesis of Helicobacter pylori infection. Clen. Microbiol. Rev 2006, 19, and 449-490.
3. Brown, L. M. Helicobacter pylori: Epidemiology and transmission routes. Epidemiol. Rev. 2000, 22, 283-297
4. Piasecki, F. Helicobacter pylori infection: Epidemiology and pathogenesis of the disease. Flora 1996, 3, 160-166.
5. Guttner, Wi. Windsor, Her Majesty; Viiala, CH; Marshall, B.J. Human recombinant lactoferrin is ineffective in the treatment of human Helicobacter pylori infection. Food. Pharmacol. Over there. 2003 ، 17 ، 125-129.
6. Genie, sa ; real servant, H. Sebghatulahi، V.; Ahmadi, B. Nutritional factors associated with the bacterium Helicobacter pylori. Gastronoterol. Accuracy. Practice. 2014 ، 2014 ، 826910.
7. Franceschi, Fr. Annalisa ، T.; Teresa, D. Giovanna, Dr. Ianero, G.; Franco, S. Viviana, J. Valentina, t ; Ricardo, LL; Antonio, G. The role of Helicobacter pylori infection in nutrition and metabolism. Scientist J. Gastroenterol. 2014 ، 20 ، 12809-12817.
8. Hooi JK, Lai WY, Ng WK, Suen MM, Underwood FE, Tanyingoh D, et al. (August 2017). "Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis". Gastroenterology. 153 (2): 420–429. doi:10.1053/j.gastro.2017.04.022. PMID 28456631
9. Susan Bernstein (2020), what is H. pylori (medical review by Minch Khatri, MD).
10. Goodwin, CS (1993) Worsley, PW. Microbiology of Helicobacter pylori. Gastronoterol. Clen. North am.
11. Suzuki, H. Nishizawa, T. Hebe, Helicobacter pylori eradication treatment. The Microbiol of the future. 2010 ، 5 ، 639-648.
12. Frawley, E. R.; Fang, F. The ins and outs of bacterial iron metabolism. Mol. Microbiol. 2014 ، 93 ، 609-616.
13. Brown (2000), L. M. Helicobacter pylori: Epidemiology and transmission routes. Epidemiol. Rev. Fr .
14. Lehor, (2018) the actual diagnosis of H. pylori infection. Minerva gastronterol. Dettol.
15. Muzammil, L. Coelho, L. G.; Bourdin, D.M Leja (2020). Review: Epidemiology of Helicobacter pylori. Helicobacter, 25 Appendix 1, e12734.
16. Marshall, (2008) B. Helicobacter pylori-Noble hunt A can. J. Gastronoterol.
17. Mihata, sparajuli, (2016), K.R.; Pant, ND;riamagi, B. Yadav, United Nations; Mehta, R. K.; Jha, P. Mehta, N. Dahmal, M. Singh, D. Prevalence and association of Helicobacter pylori infection among children under five, adolescents and non-pregnant women in Nepal: further analysis of the national survey of micronutrient status in Nepal.
18. Feldman Ra. Epidemiological observations and open questions about the disease and infection caused by Helicobacter pylori. In: Achtman M, Suer-baum S, eds. Helicobacter pylori: molecular and cellular biology. Y mondham, UK: Horizon Scientific Press, 2001.
19. PARSONITJ, Shmuli H,Haggerty T. Shed feces and mouth for heli-cobacter pylori from infected healthy adults. JAMA 1999.
20. Tyndeburg way, PLNUM, granstrom m. Clinical symptoms and social factors in a group of children who spontaneously remove Helicobacter pylori from infection. Acta Pediatr 1999; 88: 631-5.
